ImClone Systems have initiated a phase II clinical trial of its anti-IGF-1R MAb IMC-A12 in women with advanced breast cancer… more →
Kinase Newswrote 1 year ago: ImClone Systems have initiated a phase II clinical trial of its anti-IGF-1R MAb IMC-A12 in women wit … more →
wrote 1 year ago: ImClone have commenced enrollment in a Phase II trial with either IMC-A12 or IMC-1121B in patients w … more →
wrote 1 year ago: ImClone Systems have announced the start of a Phase II clinical trial of IMC-A12, its IGF-1R monoclo … more →
wrote 1 year ago: ImClone have commenced a Phase 1 clinical trial of IGF-1R MAb in combination with mTOR inhibitor tem … more →
wrote 1 year ago: ImClone’s IGF-1R receptor MAb has entered Phase II trials for Advanced Liver Cancer. It is alr … more →